Sabal Therapeutics Declares Gross sales and Advertising Settlement to Promote Athena Bioscience Cardiovascular Product Portfolio

0
46


ATHENS, Ga., Feb. 22, 2022 /PRNewswire/ — Sabal therapeutics, LLC introduced right this moment that they’ve entered into an unique gross sales and advertising settlement with Athena Bioscience, LLC to advertise Athena’s cardiovascular product portfolio. The business launch for 2 merchandise, Nexiclon™ XR and Fibricor®, will happen in April 2022.

Nexiclon XR (clonidine) is the primary and solely once-daily extended-release pill indicated for the remedy of hypertension.1 Nexiclon XR offers the antihypertensive scientific advantages of immediate-release clonidine in a handy, once-daily pill.2

Fibricor (fenofibric acid) is indicated as adjunctive remedy to weight loss program for the remedy of excessive triglycerides and excessive ldl cholesterol. Fibricor considerably improves all ldl cholesterol parameters, together with triglycerides, whole ldl cholesterol, LDL-C (“unhealthy” ldl cholesterol), and HDL-C (“good”‘ ldl cholesterol).3

“This partnership aligns completely with Sabal’s mission to help corporations by serving to them ship their merchandise to physicians and sufferers who want them,” stated Wade Harper,” Sabal’s Chief Industrial Officer. “We’re very excited to accomplice with Athena to offer a lot wanted reduction for sufferers scuffling with hypertension and excessive ldl cholesterol.”

About Sabal Therapeutics
Sabal Therapeutics presents complete pharmaceutical commercialization options to entrepreneurs and firms looking for to take part within the strong U.S. pharmaceutical market. The corporate offers vast ranging experience {and professional} assets within the areas of gross sales and advertising administration, product distribution, regulatory compliance, and accounting and back-office service and help. For added details about Sabal Therapeutics, LLC, please go to sabaltherapeutics.com.

About Athena Bioscience
Athena Bioscience, LLC is a specialty pharmaceutical firm that seeks to reinforce medical choices for each healthcare professionals and sufferers by way of revolutionary options to unmet challenges. The corporate endeavors to handle unmet wants by optimizing the usefulness of confirmed pharmaceutical therapies and delivering high quality of life enchancment to sufferers. For added details about Athena Bioscience, LLC, please go to athenabioscience.com.

  1. U.S. Meals & Drug Administration. Orange E book: Accredited Drug Merchandise with Therapeutic Equivalence Evaluations. Accesses August 1, 2021.
  2. Nexiclon XR [prescribing information]. Athens, GA: Athena Bioscience, LLC; 2021
  3. Fibricor® [prescribing information]. Athens, GA: Athena Bioscience, LLC; 2019.

SOURCE Sabal Therapeutics, LLC.



Supply hyperlink

LEAVE A REPLY

Please enter your comment!
Please enter your name here